Fresenius Medical Care traded at 41.93 this Saturday July 11th, increasing 0.09 or 0.22 percent since the previous trading session. Looking back, over the last four weeks, Fresenius Medical Care gained 5.70 percent. Over the last 12 months, its price fell by 9.81 percent. Looking ahead, we forecast Fresenius Medical Care to be priced at 40.81 by the end of this quarter and at 37.61 in one year, according to Trading Economics global macro models projections and analysts expectations.
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.